Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 367

1.

The cutting-edge morphology of the mole snake's dental apparatus.

Evans AM, Choiniere JN, Alexander GJ.

PeerJ. 2019 Jun 7;7:e6943. doi: 10.7717/peerj.6943. eCollection 2019.

2.

Foraging mode, relative prey size and diet breadth: A phylogenetically explicit analysis of snake feeding ecology.

Glaudas X, Glennon KL, Martins M, Luiselli L, Fearn S, Trembath DF, Jelić D, Alexander GJ.

J Anim Ecol. 2019 May;88(5):757-767. doi: 10.1111/1365-2656.12972. Epub 2019 Mar 22.

PMID:
30828806
3.

Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System.

Goode EC, Clark AB, Mells GF, Srivastava B, Spiess K, Gelson WTH, Trivedi PJ, Lynch KD, Castren E, Vesterhus MN, Karlsen TH, Ji SG, Anderson CA, Thorburn D, Hudson M, Heneghan MA, Aldersley MA, Bathgate A, Sandford RN, Alexander GJ, Chapman RW, Walmsley M; UK-PSC Consortium, Hirschfield GM, Rushbrook SM.

Hepatology. 2019 May;69(5):2120-2135. doi: 10.1002/hep.30479. Epub 2019 Mar 4.

4.

Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United Kingdom.

Hegade VS, Mells GF, Fisher H, Kendrick S, DiBello J, Gilchrist K, Alexander GJ, Hirschfield GM, Sandford RN, Jones DEJ; UK-PBC Consortium.

Clin Gastroenterol Hepatol. 2019 Jun;17(7):1379-1387.e3. doi: 10.1016/j.cgh.2018.12.007. Epub 2018 Dec 14.

PMID:
30557739
5.

Amino acid residues in five separate HLA genes can explain most of the known associations between the MHC and primary biliary cholangitis.

Darlay R, Ayers KL, Mells GF, Hall LS, Liu JZ, Almarri MA, Alexander GJ, Jones DE, Sandford RN, Anderson CA, Cordell HJ.

PLoS Genet. 2018 Dec 3;14(12):e1007833. doi: 10.1371/journal.pgen.1007833. eCollection 2018 Dec.

6.

Diversifying into the branches: Species boundaries in African green and bush snakes, Philothamnus (Serpentes: Colubridae).

Engelbrecht HM, Branch WR, Greenbaum E, Alexander GJ, Jackson K, Burger M, Conradie W, Kusamba C, Zassi-Boulou AG, Tolley KA.

Mol Phylogenet Evol. 2019 Jan;130:357-365. doi: 10.1016/j.ympev.2018.10.023. Epub 2018 Oct 23.

PMID:
30366085
7.

The underappreciated extent of cannibalism and ophiophagy in African cobras.

Maritz B, Alexander GJ, Maritz RA.

Ecology. 2019 Feb;100(2):e02522. doi: 10.1002/ecy.2522. Epub 2018 Oct 12. No abstract available.

PMID:
30276813
8.

Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score.

Carbone M, Nardi A, Flack S, Carpino G, Varvaropoulou N, Gavrila C, Spicer A, Badrock J, Bernuzzi F, Cardinale V, Ainsworth HF, Heneghan MA, Thorburn D, Bathgate A, Jones R, Neuberger JM, Battezzati PM, Zuin M, Taylor-Robinson S, Donato MF, Kirby J, Mitchell-Thain R, Floreani A, Sampaziotis F, Muratori L, Alvaro D, Marzioni M, Miele L, Marra F, Giannini E, Gaudio E, Ronca V, Bonato G, Cristoferi L, Malinverno F, Gerussi A, Stocken DD, Cordell HJ, Hirschfield GM, Alexander GJ, Sandford RN, Jones DE, Invernizzi P, Mells GF; Italian PBC Study Group and the UK–PBC Consortium.

Lancet Gastroenterol Hepatol. 2018 Sep;3(9):626-634. doi: 10.1016/S2468-1253(18)30163-8. Epub 2018 Jul 13.

9.

The impact of posture and basking orientation on thermoregulation in the Sungazer (Smaug giganteus).

Stanton-Jones WK, Parusnath S, Alexander GJ.

J Therm Biol. 2018 Jul;75:45-53. doi: 10.1016/j.jtherbio.2018.05.005. Epub 2018 May 26.

PMID:
30017051
10.

In vivo imaging of hepatic neutrophil migration in severe alcoholic hepatitis with 111In-radiolabelled leucocytes.

Potts JR, Farahi N, Howard MR, Taylor MR, Heard S, Shankar AN, Alexander GJ, Chilvers ER, Verma S, Peters AM.

Biosci Rep. 2018 Jul 31;38(4). pii: BSR20180466. doi: 10.1042/BSR20180466. Print 2018 Aug 31.

11.

The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.

Hirschfield GM, Dyson JK, Alexander GJM, Chapman MH, Collier J, Hübscher S, Patanwala I, Pereira SP, Thain C, Thorburn D, Tiniakos D, Walmsley M, Webster G, Jones DEJ.

Gut. 2018 Sep;67(9):1568-1594. doi: 10.1136/gutjnl-2017-315259. Epub 2018 Mar 28.

12.

Telomere, telomerase and liver disease.

Aravinthan AD, Alexander GJ.

Liver Int. 2018 Jan;38(1):33-34. doi: 10.1111/liv.13630. No abstract available.

PMID:
29272567
13.

Fine-mapping of genetic loci driving spontaneous clearance of hepatitis C virus infection.

Huang H, Duggal P, Thio CL, Latanich R, Goedert JJ, Mangia A, Cox AL, Kirk GD, Mehta S, Aneja J, Alric L, Donfield SM, Cramp ME, Khakoo SI, Tobler LH, Busch M, Alexander GJ, Rosen HR, Edlin BR, Segal FP, Lauer GM, Thomas DL, Daly MJ, Chung RT, Kim AY.

Sci Rep. 2017 Nov 20;7(1):15843. doi: 10.1038/s41598-017-16011-2.

14.

Reconstruction of the mouse extrahepatic biliary tree using primary human extrahepatic cholangiocyte organoids.

Sampaziotis F, Justin AW, Tysoe OC, Sawiak S, Godfrey EM, Upponi SS, Gieseck RL 3rd, de Brito MC, Berntsen NL, Gómez-Vázquez MJ, Ortmann D, Yiangou L, Ross A, Bargehr J, Bertero A, Zonneveld MCF, Pedersen MT, Pawlowski M, Valestrand L, Madrigal P, Georgakopoulos N, Pirmadjid N, Skeldon GM, Casey J, Shu W, Materek PM, Snijders KE, Brown SE, Rimland CA, Simonic I, Davies SE, Jensen KB, Zilbauer M, Gelson WTH, Alexander GJ, Sinha S, Hannan NRF, Wynn TA, Karlsen TH, Melum E, Markaki AE, Saeb-Parsy K, Vallier L.

Nat Med. 2017 Aug;23(8):954-963. doi: 10.1038/nm.4360. Epub 2017 Jul 3.

15.

Association between progressive hepatic morphology changes on serial MR imaging and clinical outcome in primary sclerosing cholangitis.

Kitzing YX, Whitley SA, Upponi SS, Srivastava B, Alexander GJ, Lomas DJ.

J Med Imaging Radiat Oncol. 2017 Oct;61(5):636-642. doi: 10.1111/1754-9485.12610. Epub 2017 Apr 22.

PMID:
28432731
16.

Early primary biliary cholangitis is characterised by brain abnormalities on cerebral magnetic resonance imaging.

Grover VP, Southern L, Dyson JK, Kim JU, Crossey MM, Wylezinska-Arridge M, Patel N, Fitzpatrick JA, Bak-Bol A, Waldman AD, Alexander GJ, Mells GF, Chapman RW, Jones DE, Taylor-Robinson SD.

Aliment Pharmacol Ther. 2016 Nov;44(9):936-945. doi: 10.1111/apt.13797. Epub 2016 Sep 8.

17.

BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial.

Hegade VS, Kendrick SF, Dobbins RL, Miller SR, Richards D, Storey J, Dukes G, Gilchrist K, Vallow S, Alexander GJ, Corrigan M, Hirschfield GM, Jones DE.

BMC Gastroenterol. 2016 Jul 19;16(1):71. doi: 10.1186/s12876-016-0481-9.

18.

Senescence in chronic liver disease: Is the future in aging?

Aravinthan AD, Alexander GJM.

J Hepatol. 2016 Oct;65(4):825-834. doi: 10.1016/j.jhep.2016.05.030. Epub 2016 May 28. Review.

PMID:
27245432
19.

A national survey of the provision of ultrasound surveillance for the detection of hepatocellular carcinoma.

Cross TJS, Villaneuva A, Shetty S, Wilkes E, Collins P, Adair A, Jones RL, Foxton MR, Meyer T, Stern N, Warshow U, Khan N, Prince M, Khakoo S, Alexander GJ, Khan S, Reeves H, Marshall A, Williams R.

Frontline Gastroenterol. 2016 Apr;7(2):82-89. doi: 10.1136/flgastro-2015-100617. Epub 2015 Dec 7. Erratum in: Frontline Gastroenterol. 2019 Jan;10(1):87.

20.

STAT4-associated natural killer cell tolerance following liver transplantation.

Jamil KM, Hydes TJ, Cheent KS, Cassidy SA, Traherne JA, Jayaraman J, Trowsdale J, Alexander GJ, Little AM, McFarlane H, Heneghan MA, Purbhoo MA, Khakoo SI.

Gut. 2017 Feb;66(2):352-361. doi: 10.1136/gutjnl-2015-309395. Epub 2016 Feb 17.

21.

An ambusher's arsenal: chemical crypsis in the puff adder (Bitis arietans).

Miller AK, Maritz B, McKay S, Glaudas X, Alexander GJ.

Proc Biol Sci. 2015 Dec 22;282(1821):20152182. doi: 10.1098/rspb.2015.2182.

22.

Persistence of Hepatitis C Virus Traces after Spontaneous Resolution of Hepatitis C.

Chen AY, Hoare M, Shankar AN, Allison M, Alexander GJ, Michalak TI.

PLoS One. 2015 Oct 16;10(10):e0140312. doi: 10.1371/journal.pone.0140312. eCollection 2015.

23.

The interaction of genetic determinants in the outcome of HCV infection: evidence for discrete immunological pathways.

Hydes TJ, Moesker B, Traherne JA, Ashraf S, Alexander GJ, Dimitrov BD, Woelk CH, Trowsdale J, Khakoo SI.

Tissue Antigens. 2015 Oct;86(4):267-75. doi: 10.1111/tan.12650.

24.

The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis.

Carbone M, Sharp SJ, Flack S, Paximadas D, Spiess K, Adgey C, Griffiths L, Lim R, Trembling P, Williamson K, Wareham NJ, Aldersley M, Bathgate A, Burroughs AK, Heneghan MA, Neuberger JM, Thorburn D, Hirschfield GM, Cordell HJ, Alexander GJ, Jones DE, Sandford RN, Mells GF; UK-PBC Consortium.

Hepatology. 2016 Mar;63(3):930-50. doi: 10.1002/hep.28017. Epub 2015 Oct 20.

PMID:
26223498
25.

Correction: Chronic Hepatitis B Virus Infection: The Relation between Hepatitis B Antigen Expression, Telomere Length, Senescence, Inflammation and Fibrosis.

Tachtatzis PM, Marshall A, Aravinthan A, Verma S, Penrhyn-Lowe S, Mela M, Scarpini C, Davies SE, Coleman N, Alexander GJ.

PLoS One. 2015 Jul 28;10(7):e0134315. doi: 10.1371/journal.pone.0134315. eCollection 2015. No abstract available.

26.

Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation.

Sampaziotis F, de Brito MC, Madrigal P, Bertero A, Saeb-Parsy K, Soares FAC, Schrumpf E, Melum E, Karlsen TH, Bradley JA, Gelson WT, Davies S, Baker A, Kaser A, Alexander GJ, Hannan NRF, Vallier L.

Nat Biotechnol. 2015 Aug;33(8):845-852. doi: 10.1038/nbt.3275. Epub 2015 Jul 13.

27.

Chronic Hepatitis B Virus Infection: The Relation between Hepatitis B Antigen Expression, Telomere Length, Senescence, Inflammation and Fibrosis.

Tachtatzis PM, Marshall A, Arvinthan A, Verma S, Penrhyn-Lowe S, Mela M, Scarpini C, Davies SE, Coleman N, Alexander GJ.

PLoS One. 2015 May 29;10(5):e0127511. doi: 10.1371/journal.pone.0127511. eCollection 2015. Erratum in: PLoS One. 2015;10(7):e0134315. Aravinthan, Aloysius [corrected to Arvinthan, Aloysious].

28.

Magnetic resonance elastography in the detection of hepatorenal syndrome in patients with cirrhosis and ascites.

Low G, Owen NE, Joubert I, Patterson AJ, Graves MJ, Alexander GJ, Lomas DJ.

Eur Radiol. 2015 Oct;25(10):2851-8. doi: 10.1007/s00330-015-3723-2. Epub 2015 Apr 23.

PMID:
25903705
29.

Renal impairment in cirrhosis unrelated to hepatorenal syndrome.

Low G, Alexander GJ, Lomas DJ.

Can J Gastroenterol Hepatol. 2015 Jun-Jul;29(5):253-7. Epub 2015 Apr 15. Review.

30.

Hepatocyte senescence explains conjugated bilirubinaemia in chronic liver failure.

Aravinthan AD, Alexander GJ.

J Hepatol. 2015 Aug;63(2):532-3. doi: 10.1016/j.jhep.2015.03.031. Epub 2015 Apr 1. No abstract available.

31.

Hepatorenal syndrome: aetiology, diagnosis, and treatment.

Low G, Alexander GJ, Lomas DJ.

Gastroenterol Res Pract. 2015;2015:207012. doi: 10.1155/2015/207012. Epub 2015 Jan 12. Review.

32.

Reliability of magnetic resonance elastography using multislice two-dimensional spin-echo echo-planar imaging (SE-EPI) and three-dimensional inversion reconstruction for assessing renal stiffness.

Low G, Owen NE, Joubert I, Patterson AJ, Graves MJ, Glaser KJ, Alexander GJ, Lomas DJ.

J Magn Reson Imaging. 2015 Sep;42(3):844-50. doi: 10.1002/jmri.24826. Epub 2014 Dec 24.

33.

A retrospective 15-year review: survival advantage after switching to sirolimus in hepatitis C virus infected liver graft recipients.

Shah M, Shankar A, Gee I, Nash K, Hoare M, Gibbs P, Davies S, Alexander GJ.

Aliment Pharmacol Ther. 2015 Feb;41(4):379-92. doi: 10.1111/apt.13049. Epub 2014 Dec 11.

34.

Characterising the association of latency with α(1)-antitrypsin polymerisation using a novel monoclonal antibody.

Tan L, Perez J, Mela M, Miranda E, Burling KA, Rouhani FN, DeMeo DL, Haq I, Irving JA, Ordóñez A, Dickens JA, Brantly M, Marciniak SJ, Alexander GJ, Gooptu B, Lomas DA.

Int J Biochem Cell Biol. 2015 Jan;58:81-91. doi: 10.1016/j.biocel.2014.11.005. Epub 2014 Nov 13.

35.

Selective insulin resistance in hepatocyte senescence.

Aravinthan A, Challis B, Shannon N, Hoare M, Heaney J, Alexander GJ.

Exp Cell Res. 2015 Feb 1;331(1):38-45. doi: 10.1016/j.yexcr.2014.09.025. Epub 2014 Sep 28.

PMID:
25263463
36.

The senescent hepatocyte gene signature in chronic liver disease.

Aravinthan A, Shannon N, Heaney J, Hoare M, Marshall A, Alexander GJ.

Exp Gerontol. 2014 Dec;60:37-45. doi: 10.1016/j.exger.2014.09.011. Epub 2014 Sep 18.

PMID:
25240687
37.

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.

Liu YL, Reeves HL, Burt AD, Tiniakos D, McPherson S, Leathart JB, Allison ME, Alexander GJ, Piguet AC, Anty R, Donaldson P, Aithal GP, Francque S, Van Gaal L, Clement K, Ratziu V, Dufour JF, Day CP, Daly AK, Anstee QM.

Nat Commun. 2014 Jun 30;5:4309. doi: 10.1038/ncomms5309.

38.

Digestive efficiencies are independent of gut passage times in rainbow skinks (Trachylepis margaritifer).

Miller AK, Erasmus BF, Alexander GJ.

Comp Biochem Physiol A Mol Integr Physiol. 2014 Sep;175:110-4. doi: 10.1016/j.cbpa.2014.06.002. Epub 2014 Jun 15.

PMID:
24937258
39.

Rifaximin is largely safe and well tolerated but caution is necessary when taken with statins.

Cacciottolo TM, Kingdon A, Alexander GJ.

Clin Gastroenterol Hepatol. 2014 Oct;12(10):1765. doi: 10.1016/j.cgh.2014.03.027. Epub 2014 Apr 1. No abstract available.

PMID:
24703862
40.

Extended duration therapy with pegylated interferon and ribavirin for patients with genotype 3 hepatitis C and advanced fibrosis: final results from the STEPS trial.

Shoeb D, Dearden J, Weatherall A, Bargery C, Moreea S, Alam S, White E, Vila X, Freshwater D, Ryder S, Mills PR, Alexander GJ, Forton D, Foster GR.

J Hepatol. 2014 Apr;60(4):699-705. doi: 10.1016/j.jhep.2013.11.011. Epub 2013 Nov 26.

PMID:
24291239
41.

Hepatocyte expression of the senescence marker p21 is linked to fibrosis and an adverse liver-related outcome in alcohol-related liver disease.

Aravinthan A, Pietrosi G, Hoare M, Jupp J, Marshall A, Verrill C, Davies S, Bateman A, Sheron N, Allison M, Alexander GJ.

PLoS One. 2013 Sep 23;8(9):e72904. doi: 10.1371/journal.pone.0072904. eCollection 2013.

42.

Infectious aortitis in a liver transplant recipient.

Gerada J, Ganeshanantham G, Dawwas MF, Winterbottom AP, Sivaprakasam R, Butler AJ, Alexander GJ.

Am J Transplant. 2013 Sep;13(9):2479-82. doi: 10.1111/ajt.12353. Epub 2013 Aug 6. Erratum in: Am J Transplant. 2014 Jan;14(1):243.

43.

Age-related macular degeneration and modification of systemic complement factor H production through liver transplantation.

Khandhadia S, Hakobyan S, Heng LZ, Gibson J, Adams DH, Alexander GJ, Gibson JM, Martin KR, Menon G, Nash K, Sivaprasad S, Ennis S, Cree AJ, Morgan BP, Lotery AJ.

Ophthalmology. 2013 Aug;120(8):1612-8. doi: 10.1016/j.ophtha.2013.01.004. Epub 2013 Apr 4.

PMID:
23562165
44.

Impact of primary biliary cirrhosis on perceived quality of life: the UK-PBC national study.

Mells GF, Pells G, Newton JL, Bathgate AJ, Burroughs AK, Heneghan MA, Neuberger JM, Day DB, Ducker SJ, Sandford RN, Alexander GJ, Jones DE; UK-PBC Consortium.

Hepatology. 2013 Jul;58(1):273-83. doi: 10.1002/hep.26365.

PMID:
23471852
45.

The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort.

Pells G, Mells GF, Carbone M, Newton JL, Bathgate AJ, Burroughs AK, Heneghan MA, Neuberger JM, Day DB, Ducker SJ; UK-PBC Consortium, Sandford RN, Alexander GJ, Jones DE.

J Hepatol. 2013 Jul;59(1):67-73. doi: 10.1016/j.jhep.2013.02.019. Epub 2013 Mar 4.

PMID:
23466308
46.

Calcineurin inhibitors and the IL12A locus influence risk of recurrent primary biliary cirrhosis after liver transplantation.

Carbone M, Mells GF, Alexander GJ, Westbrook RH, Heneghan MA, Sandford RN, Neuberger JM.

Am J Transplant. 2013 Apr;13(4):1110-1111. doi: 10.1111/ajt.12132. Epub 2013 Feb 22. No abstract available.

47.

Prevalence and risk factors for liver involvement in individuals with PiZZ-related lung disease.

Dawwas MF, Davies SE, Griffiths WJ, Lomas DA, Alexander GJ.

Am J Respir Crit Care Med. 2013 Mar 1;187(5):502-8. doi: 10.1164/rccm.201204-0739OC. Epub 2012 Dec 21.

PMID:
23262512
48.

γ-H2AX+CD8+ T lymphocytes cannot respond to IFN-α, IL-2 or IL-6 in chronic hepatitis C virus infection.

Hoare M, Shankar A, Shah M, Rushbrook S, Gelson W, Davies S, Akbar A, Alexander GJ.

J Hepatol. 2013 May;58(5):868-74. doi: 10.1016/j.jhep.2012.12.009. Epub 2012 Dec 17.

49.

Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid.

Carbone M, Mells GF, Pells G, Dawwas MF, Newton JL, Heneghan MA, Neuberger JM, Day DB, Ducker SJ; UK PBC Consortium, Sandford RN, Alexander GJ, Jones DE.

Gastroenterology. 2013 Mar;144(3):560-569.e7; quiz e13-4. doi: 10.1053/j.gastro.2012.12.005. Epub 2012 Dec 12.

PMID:
23246637
50.

Induced pluripotent stem cells: from Nobel Prizes to clinical applications.

Rashid ST, Alexander GJ.

J Hepatol. 2013 Mar;58(3):625-9. doi: 10.1016/j.jhep.2012.10.026. Epub 2012 Nov 3. Review.

Supplemental Content

Loading ...
Support Center